Impact of a beta-blocker therapy with metoprolol or carvedilol on the activity of radical scavenger enzymes in the skeletal muscle of patients with chronic heart failure

被引：0
|
作者：
Linke, A [1 ]
Adams, V [1 ]
Kolloch, J [1 ]
Erbs, S [1 ]
Gielen, S [1 ]
Schoene, N [1 ]
Schuler, G [1 ]
Hambrecht, R [1 ]
机构：
[1] Univ Leipzig, Ctr Heart, Leipzig, Germany
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1726
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [31] Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
    Kotecha, Dipak
    Gill, Simrat K.
    Flather, Marcus D.
    Holmes, Jane
    Packer, Milton
    Rosano, Giuseppe
    Boehm, Michael
    McMurray, John J. V.
    Wikstrand, John
    Anker, Stefan D.
    van Veldhuisen, Dirk J.
    Manzano, Luis
    von Lueder, Thomas G.
    Rigby, Alan S.
    Andersson, Bert
    Kjekshus, John
    Wedel, Hans
    Ruschitzka, Frank
    Cleland, John G. F.
    Damman, Kevin
    Redon, Josep
    Coats, Andrew J. S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (23) : 2893 - 2904
  • [32] ANTIHYPERTENSIVE THERAPY WITH THE VASODILATING BETA-BLOCKER CARVEDILOL - COMPARISON OF ACUTE AND SUBCHRONIC CARDIOVASCULAR EFFECTS WITH METOPROLOL
    BOHMEKE, T
    WEBER, K
    VANDERDOES, R
    NOCKER, B
    RICKEN, D
    HERZ KREISLAUF, 1994, 26 (01): : 22 - 26
  • [33] BENEFIT AND LIMITATION OF BETA-BLOCKER THERAPY FOR TREATMENT OF CHRONIC HEART-FAILURE
    HORI, M
    SATO, H
    SATO, H
    KAMADA, T
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 : S37 - S37
  • [34] New advances in beta-blocker therapy in heart failure
    Barrese, Vincenzo
    Taglialatela, Maurizio
    FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [35] Effectiveness of combined beta-blocker and ACEI or ARB therapy in chronic heart failure
    Sharma, M.
    Deswal, A.
    Henderson, L.
    Desai, R.
    Chitnis, A.
    Petersen, N.
    Ashton, C.
    Johnson, M.
    VALUE IN HEALTH, 2008, 11 (03) : A16 - A16
  • [36] ACUTE HEMODYNAMIC-EFFECTS OF THE BETA-BLOCKER CARVEDILOL IN HEART-FAILURE
    BUCHWALD, A
    UNTERBERG, C
    VANDERDOES, R
    WIEGAND, V
    ZEITSCHRIFT FUR KARDIOLOGIE, 1990, 79 (06): : 424 - 428
  • [37] Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial
    Metra, M
    Torp-Pedersen, C
    Swedberg, K
    Cleland, JGF
    Di Lenarda, A
    Komajda, M
    Remme, WJ
    Lutiger, B
    Scherhag, A
    Lukas, MA
    Charlesworth, A
    Poole-Wilson, PA
    EUROPEAN HEART JOURNAL, 2005, 26 (21) : 2259 - 2268
  • [38] Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial
    Mazhar, Raoul
    JOURNAL FUR KARDIOLOGIE, 2005, 12 (9-10): : 260 - 260
  • [39] Prevalence and prognostic significance of adrenergic escape under chronic beta-blocker therapy in patients with chronic heart failure
    Frankenstein, L.
    Zugck, C.
    Schellberg, D.
    Froehlich, H.
    Nelles, M.
    Katus, H.
    Remppis, A.
    EUROPEAN HEART JOURNAL, 2008, 29 : 178 - 178
  • [40] Chronic beta-blocker treatment in patients with advanced heart failure - Effects on neurohormones
    Teisman, ACH
    van Veldhuisen, DJ
    Boomsma, F
    de Kam, PJ
    Tjeerdsma, G
    Pinto, YM
    de Zeeuw, D
    van Gilst, WH
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 73 (01) : 7 - 12
12345